R
Ranjit Mohan Anjana
Researcher at Indian Council of Medical Research
Publications - 300
Citations - 30665
Ranjit Mohan Anjana is an academic researcher from Indian Council of Medical Research. The author has contributed to research in topics: Diabetes mellitus & Medicine. The author has an hindex of 46, co-authored 221 publications receiving 21128 citations. Previous affiliations of Ranjit Mohan Anjana include Madras Medical College.
Papers
More filters
Journal ArticleDOI
Self-efficacy and diabetes prevention in overweight South Asians with pre-diabetes.
Catherine E. Cioffi,Harish Ranjani,Lisa R. Staimez,Ranjit Mohan Anjana,Viswanathan Mohan,Mary Beth Weber +5 more
TL;DR: Several short-term and long-term secondary outcomes, but not diabetes risk, were significantly associated with exercise SE, suggesting this psychosocial trait may facilitate success in achieving certain health goals.
Journal ArticleDOI
1598-P: Incidence of Diabetes in South Asian Adults in Urban India/Pakistan Compared with Blacks and Whites in U.S.
K.M. Venkat Narayan,Dimple Kondal,Natalie Daya,Shivani A. Patel,Mohan Deepa,Ranjit Mohan Anjana,Lisa R. Staimez,Unjali P. Gujral,Sayuko Kobes,Roopa Shivashankar,Mohammed K. Ali,Masood Kadir,Dorairaj Prabhakaran,Robert L. Hanson,Viswanathan Mohan,Elizabeth Selvin,Nikhil Tandon +16 more
TL;DR: Even nonobese South Asian adults have markedly higher risk of diabetes compared to whites, and in those with BMI Adults in urban India/Pakistan have higher diabetes incidence than U.S. whites.
Journal ArticleDOI
Clinical utility of 30-min plasma glucose for prediction of type 2 diabetes among people with prediabetes: Ancillary analysis of the diabetes community lifestyle improvement program.
Ram Jagannathan,Mary Beth Weber,Ranjit Mohan Anjana,Harish Ranjani,Lisa R. Staimez,Mohammed K. Ali,Viswanathan Mohan,K.M. Venkat Narayan +7 more
TL;DR: In prediabetic individuals, baseline 30-min-PG independently predicted type 2 diabetes and significantly improved reclassification and discrimination and should be considered as part of the routine testing in addition to FPG and 2-h-PG for better risk stratification.
Journal ArticleDOI
Cohort Profile: The Center for cArdiometabolic Risk Reduction in South Asia (CARRS).
Dimple Kondal,Shivani A. Patel,Mohammed K. Ali,Deepa Mohan,Garima Rautela,Unjali P. Gujral,Roopa Shivashankar,Ranjit Mohan Anjana,Ruby Gupta,Deksha Kapoor,Ajay Vamadevan,Sailesh Mohan,Muhammad Masood Kadir,Viswanathan Mohan,Nikhil Tandon,Dorairaj Prabhakaran,K.M. Venkat Narayan +16 more
TL;DR: The Center for cArdiometabolic Risk Reduction in South Asia (CARRS) as mentioned in this paper is a population-based representative sociodemographically diverse cohort of 30 874 adults with prospective follow-up in three major cities in India and Karachi in Pakistan.
Posted ContentDOI
Low uptake of COVID-19 prevention behaviours and high socioeconomic impact of lockdown measures in South Asia: evidence from a large-scale multi-country surveillance programme
Dian Kusuma,Rajendra Pradeepa,Khadija Irfan Khawaja,Mehedi Hasan,Samreen Siddiqui,Sara Mahmood,Syed Mohsin Ali Shah,Chamini K. De Silva,Laksara de Silva,Manoja Gamage,Menka Loomba,Vindya P. Rajakaruna,Abu Am Hanif,Rajan Kamalesh,Balachandran Kumarendran,Marie Loh,Marie Loh,Archa Misra,Asma Tassawar,Akansha Tyagi,Swati Waghdhare,Saira Burney,Sajjad Ahmad,Viswanathan Mohan,Malabika Sarker,Ian Y. Goon,Anuradhani Kasturiratne,Jaspal S. Kooner,Prasad Katulanda,Sujeet Jha,Ranjit Mohan Anjana,Malay K Mridha,Franco Sassi,John C. Chambers,John C. Chambers +34 more
TL;DR: The results identified important knowledge, access and uptake barriers to the prevention of COVID-19 in South Asia, and demonstrated major adverse impacts of the pandemic on chronic disease treatment, mental health, health-related behaviours, employment and household finances.